Cargando…

Pandemics, intermediate goods, and corporate valuation()

We evaluate whether the changes in valuation of U.S. corporates during the first wave of the COVID-19 pandemic depend on their downstream or upstream industries’ exposure to social distancing. Using a new dataset on sectoral dependence on the use and sale of intermediate goods, we find that firms wh...

Descripción completa

Detalles Bibliográficos
Autor principal: Laeven, Luc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756216/
https://www.ncbi.nlm.nih.gov/pubmed/36540771
http://dx.doi.org/10.1016/j.jimonfin.2021.102505
_version_ 1784851585383268352
author Laeven, Luc
author_facet Laeven, Luc
author_sort Laeven, Luc
collection PubMed
description We evaluate whether the changes in valuation of U.S. corporates during the first wave of the COVID-19 pandemic depend on their downstream or upstream industries’ exposure to social distancing. Using a new dataset on sectoral dependence on the use and sale of intermediate goods, we find that firms whose downstream sectors are more affected by social distancing suffer from a greater decline in stock prices during the first quarter of 2020. Such an effect is mitigated for large firms.
format Online
Article
Text
id pubmed-9756216
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-97562162022-12-16 Pandemics, intermediate goods, and corporate valuation() Laeven, Luc J Int Money Finance Article We evaluate whether the changes in valuation of U.S. corporates during the first wave of the COVID-19 pandemic depend on their downstream or upstream industries’ exposure to social distancing. Using a new dataset on sectoral dependence on the use and sale of intermediate goods, we find that firms whose downstream sectors are more affected by social distancing suffer from a greater decline in stock prices during the first quarter of 2020. Such an effect is mitigated for large firms. Elsevier Ltd. 2022-02 2021-09-25 /pmc/articles/PMC9756216/ /pubmed/36540771 http://dx.doi.org/10.1016/j.jimonfin.2021.102505 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Laeven, Luc
Pandemics, intermediate goods, and corporate valuation()
title Pandemics, intermediate goods, and corporate valuation()
title_full Pandemics, intermediate goods, and corporate valuation()
title_fullStr Pandemics, intermediate goods, and corporate valuation()
title_full_unstemmed Pandemics, intermediate goods, and corporate valuation()
title_short Pandemics, intermediate goods, and corporate valuation()
title_sort pandemics, intermediate goods, and corporate valuation()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756216/
https://www.ncbi.nlm.nih.gov/pubmed/36540771
http://dx.doi.org/10.1016/j.jimonfin.2021.102505
work_keys_str_mv AT laevenluc pandemicsintermediategoodsandcorporatevaluation